Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-05-20
1999-11-30
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142232, 5142228, 424465, A61K 3141, A61K 31415, A61K 3144, A61K 920
Patent
active
059943483
ABSTRACT:
Pharmaceutical compositions containing irbesartan, alone or in combination with a diuretic, providing tablets with a high relative amount of active agent and excellent wetting and disintegration properties.
REFERENCES:
patent: 4414198 (1983-11-01), Michaelson
patent: 4769236 (1988-09-01), Panoz et al.
patent: 4793999 (1988-12-01), Sheth
patent: 4804540 (1989-02-01), Nugent et al.
patent: 4808413 (1989-02-01), Joshi et al.
patent: 4898729 (1990-02-01), Miller et al.
patent: 4904699 (1990-02-01), Bauer
patent: 4910022 (1990-03-01), Bavitz et al.
patent: 4952410 (1990-08-01), Armah et al.
patent: 5006344 (1991-04-01), Jerzewski et al.
patent: 5037823 (1991-08-01), Jones et al.
patent: 5047246 (1991-09-01), Gallian et al.
patent: 5049394 (1991-09-01), Howard et al.
patent: 5073374 (1991-12-01), McCarty
patent: 5087454 (1992-02-01), Duerholz et al.
patent: 5112616 (1992-05-01), McCarty
patent: 5155105 (1992-10-01), Jones et al.
patent: 5270317 (1993-12-01), Bernhart et al.
patent: 5288501 (1994-02-01), Nurnberg et al.
patent: 5298261 (1994-03-01), Pebley et al.
patent: 5370870 (1994-12-01), Shah
patent: 5370878 (1994-12-01), Shah
patent: 5393531 (1995-02-01), Gerhard et al.
patent: 5424075 (1995-06-01), Daher et al.
patent: 5464632 (1995-11-01), Cousin et al.
patent: 5464854 (1995-11-01), dePadova
patent: 5501861 (1996-03-01), Makino et al.
patent: 5503845 (1996-04-01), Goede et al.
patent: 5541209 (1996-07-01), Spinale
patent: 5753651 (1998-05-01), dePadova
Abstract of Desai et al Int. Jl. Pharmaceutics 142 (11:61-66 "Povidone. and Poloxamer-Mediated Degradation of Hydrochlorothiazide in an Anti Hypertensive Combination Tablet Product", 1996.
Desai et al., "Effect of formaldehyde formation on dissolution stability on hydrochlorothiazide bead formulations", International Journal of Pharmaceutics, 107(2) 141-147 (1994).
Desai et al., "Effects of different types of lactose and disintegrant on dissolution stability of hydrochlorothiazide capsule formulations", International Journal of Pharmaceutics, 110, 257-265 (1994).
BASF, "Pluronic.RTM. & Tetronic.RTM. Surfactants," pp. 1-29 (1989).
I.R. Schmolka, "Poloxamers in the Pharmaceutical Industry", "Polymers For Controlled Drug Delivery", (ed. P. J. Tarcha) (1991) pp. 189, 193, 197, 201, 205, 209 and 213.
Poloxamer, Handbook of Pharmaceutical Excipients, pp. 207-208 (1986).
Official Monographs, Poloxamer, USP23/NF18, pp. 2279-2281 (195).
Physicians' Desk Reference, World Search Report, Jan. 31, 1994, "poloxamer", with attachments (the latter: formulations of Benylin DM, Cleocin Pediatric, Colace, Lariam, Peri-colace, Pediazole, Almay Eyelid, Baby Orajel and Geriplex-FS).
Lachman, L. et al., "The Theory and Practice of Industrial Pharmacy", Third Edition, (1986), cover page and p. 321.
Poloxamer, Handbook of Pharmaceutical Excipients, 2.sup.nd Edition, pp. 352-354 (1995).
Povidone, Handbook of Pharmaceutical Excipients, 2.sup.nd Edition, pp. 392, 396 and 399 (1995).
Desai Divyakant S.
Ku Cathy C.
Lang Beth A.
Sprockel Omar L.
Alexander Michael D.
Rose Shep K.
Sanofi
LandOfFree
Pharmaceutical compositions containing irbesartan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing irbesartan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing irbesartan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672875